|
Video: What is a Stock Split?
|
|
Biotricity is a medical technology company focused on biometric data monitoring solutions. Co. delivers remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Co.'s Bioflux is an integrated electrocardiogram device and software solution for the mobile cardiac telemetry market. The Bioflux platform has a built-in cellular chipset and a real-time embedded operating system which allows for Co.'s technology to be utilized as an Internet of Things platform. This technology can be utilized into other applications and industries by utilizing the platform and OS side of Bioflux. According to our Biotricity stock split history records, Biotricity has had 1 split. | |
|
Biotricity (BTCY) has 1 split in our Biotricity stock split history database. The split for BTCY took place on July 03, 2023. This was a 1 for 6 reverse split, meaning for each 6 shares of BTCY owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.
When a company such as Biotricity conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Biotricity stock split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biotricity shares, starting with a $10,000 purchase of BTCY, presented on a split-history-adjusted basis factoring in the complete Biotricity stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/20/2018 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$24.36 |
|
End price/share: |
$1.28 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.75% |
|
Average Annual Total Return: |
-37.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$525.66 |
|
Years: |
6.18 |
|
|
|
Date |
Ratio |
07/03/2023 | 1 for 6 |
|
|